Kepler Capital Markets set a €34.50 ($40.12) price target on Jenoptik (ETR:JEN) in a research report released on Thursday. The brokerage currently has a neutral rating on the stock.

Other analysts have also recently issued reports about the company. Baader Bank set a €30.00 ($34.88) price objective on Jenoptik and gave the stock a neutral rating in a research report on Thursday. Hauck & Aufhaeuser set a €34.50 ($40.12) price objective on Jenoptik and gave the stock a buy rating in a research report on Thursday, February 28th. Warburg Research set a €33.00 ($38.37) price objective on Jenoptik and gave the stock a buy rating in a research report on Wednesday, February 13th. HSBC set a €30.00 ($34.88) price objective on Jenoptik and gave the stock a neutral rating in a research report on Thursday, February 14th. Finally, DZ Bank reissued a neutral rating on shares of Jenoptik in a research note on Wednesday, February 13th. One research analyst has rated the stock with a sell rating and seven have assigned a hold rating to the company’s stock. The stock presently has a consensus rating of Hold and an average target price of €31.21 ($36.30).

Jenoptik stock opened at €32.90 ($38.26) on Thursday. Jenoptik has a twelve month low of €22.02 ($25.60) and a twelve month high of €39.54 ($45.98). The company has a quick ratio of 1.22, a current ratio of 2.18 and a debt-to-equity ratio of 23.51. The company has a market cap of $1.88 billion and a price-to-earnings ratio of 22.88.

Jenoptik Company Profile

Jenoptik AG operates as an integrated photonics company in Germany and internationally. The company's Opticals & Life Science division develops and manufactures micro-optics for beam shaping for use in the semiconductor industry, as well as for laser material processing; and optical systems and components for information and communication, security, and defense technologies.

Further Reading: What is a Swap?

Analyst Recommendations for Jenoptik (ETR:JEN)

Receive News & Ratings for Jenoptik Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jenoptik and related companies with MarketBeat.com's FREE daily email newsletter.